Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEST-DKA
NCT05752279Phase 3Completed
- Sponsor
- The George Institute for Global Health
- Start
- Mar 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of plasma-lyte in diabetic ketoacidosis (DKA), sponsored by The George Institute for Global Health. Started Mar 2024; status: completed.
02
Drugs
plasma-lyte
03
Conditions
diabetic ketoacidosis (DKA)
Beyond the preview
Go deeper on NCT05752279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05752279.